S'abonner

Readmission following surgical procedures: Implications for quality improvement and cost savings - 24/08/11

Doi : 10.1016/j.jamcollsurg.2011.06.247 
Elise H. Lawson, MD, MSHS, Bruce Lee Hall, MD, PhD, MBA, Rachel Louie, MS, David S. Zingmond, MD, PhD, Clifford Y. Ko, MD, MS, FACS
David Geffen School of Medicine at UCLA, Los Angeles, CA, School of Medicine, Washington University in St Louis, Saint Louis, MO and American College of Surgeons, Chicago, IL 

Résumé

Introduction

Policymakers are increasingly targeting readmission for quality improvement and cost savings. Our objective was to characterize readmission following surgical procedures and estimate cost savings if readmissions are reduced.

Methods

Eligible patient-level records from the National Surgical Quality Improvement Program (NSQIP), years 2005-2008, were linked to Medicare inpatient claims data using indirect patient identifiers. Risk factors, indication for surgery (ICD9 code), and 30-day postoperative adverse events (PAE) were determined from NSQIP while 30-day readmission and costs were determined from Medicare. Poisson models were developed to determine incident rates of readmission, accounting for mortality.

Results

Of the 114,288 patients in the linked database who were discharged alive, 16,541 were readmitted within 30 days of surgery. The incident rate of readmission, accounting for mortality, was 15.7%. Procedures most frequently associated with readmission were open colectomy, carotid artery procedures, and lower extremity bypass. Indications for surgery most frequently associated with later readmission were arterial aneurysms, atherosclerosis, arterial occlusion, colon cancer and abdominal hernia. Patients with any PAE had an incident rate of 30-day readmission of 42.9%, while patients with no PAE had an incident rate of 10.8%. The average Medicare payment for readmission was $10,684 (SD $13,751). Readmissions associated with a prior PAE cost on average $2,524 more than readmissions with no associated PAE. Reducing the complication rates for the above three procedures by a relative 5% each would result in an estimated savings of more than $19.1 million per year.
Costs associated with 30-day readmission and estimated savings if PAE are reduced by a relative 5%Open ColectomyCarotid ProceduresLower Extremity BypassPAE rate28.0%5.6%20.9%Number of discharges/year^297,902115,04063,585Incident rate of 30-day readmission if any PAE35.1%65.2%60.6%Incident rate of 30-day readmission if no PAE11.3%9.3%14.6%Mean cost of a 30-day readmission if any PAE$11,682$12,556$11,399Mean cost of a 30-day readmission if no PAE$8,171$10,865$10,345Reduce PAE rate by relative 5%:Reduced PAE rate26.6%5.3%19.8%Estimated readmissions saved per 1000 patients undergoing procedure3.31.64.8Estimated annual costs saved$13.2 million$2.3 million$3.6 millionPAE = 30-day postoperative adverse event recorded in NSQIPFor patients discharged alive within 30-days of primary procedure^Nationwide Inpatient Sample, 2008

 Open Colectomy Carotid Procedures Lower Extremity Bypass 
PAE rate 28.0% 5.6% 20.9% 
Number of discharges/year^ 297,902 115,040 63,585 
Incident rate of 30-day readmission if any PAE 35.1% 65.2% 60.6% 
Incident rate of 30-day readmission if no PAE 11.3% 9.3% 14.6% 
Mean cost of a 30-day readmission if any PAE $11,682 $12,556 $11,399 
Mean cost of a 30-day readmission if no PAE $8,171 $10,865 $10,345 
Reduce PAE rate by relative 5%:    
Reduced PAE rate 26.6% 5.3% 19.8% 
Estimated readmissions saved per 1000 patients undergoing procedure 3.3 1.6 4.8 
Estimated annual costs saved $13.2 million $2.3 million $3.6 million 

PAE = 30-day postoperative adverse event recorded in NSQIP

[]  For patients discharged alive within 30-days of primary procedure
[^]  Nationwide Inpatient Sample, 2008

Conclusions

Readmission following surgical procedures is common and represents an opportunity for quality improvement and cost savings.

Le texte complet de cet article est disponible en PDF.

© 2011  American College of Surgeons. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 213 - N° 3S

P. S106 - septembre 2011 Retour au numéro
Article précédent Article précédent
  • Activation of naïve CD8+ T cells by memory cells impairs antitumor immunity in adoptive cell transfer
  • Christopher Dean Scott, Christopher A. Klebanoff, Rahul Roychoudhuri, Sid P. Kerkar, Zachary A. Borman, Steven A. Rosenberg, Nicholas P. Restifo
| Article suivant Article suivant
  • Racial variation in the quality of care among patients undergoing cystectomy for bladder cancer
  • Daniel A. Barocas, Darryl T. Gray, Jay H. Fowke, Sam S. Chang, Michael S. Cookson, Joseph A. Smith, David F. Penson

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.